Male breast cancer: clinicopathological features and prevalence of germline pathogenic variants
Breast Cancer Research and Treatment · 2026-11 · 220 (1)
DOI: 10.1007/s10549-026-08062-9 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 04.11.2026. Verfasst von P V B D Cerqueira und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Instituto De Assistência Médica Ao Servidor Público Estadual, Pedro de Toledo, 1800, São Paulo, 04039-000, Brasil. patrickbat…. Hauptthemen laut MEDLINE: Breast Neoplasms, Male, Germ-Line Mutation, Genetic Predisposition to Disease, Biomarkers, Tumor. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto De Assistência Médica Ao Servidor Público Estadual.
Abstract (Originalsprache)
Purpose
Male breast cancer is rare, and data on its clinicopathological and germline characteristics remain scarce. Our objective was to describe the clinicopathological profile of men with breast cancer and to estimate the prevalence of pathogenic germline variants in cancer predisposition genes.
Methods
This multicenter retrospective study included adult men diagnosed with breast cancer between January 2000 and June 2022 at two institutions. Clinical and pathological data were obtained from medical records. Germline analysis was performed in patients without prior testing using DNA from biobanks or saliva samples and a custom multigene panel.
Results
A total of 106 patients were included. Median age at diagnosis was 58.5 years (range, 33–84), and 64% reported a family history of cancer. Invasive ductal carcinoma was the predominant histological subtype (88%). Most tumors were grade 2 or 3 (90%) and hormone receptor-positive (93%). Hormone receptor-negative/HER2-positive disease was rare (1%), and triple-negative breast cancer accounted for 4% of cases. At diagnosis, 65% had stage II or III disease. Germline testing was performed in 55 patients, of whom 12 (22%) harbored pathogenic or likely pathogenic variants. The most frequently affected gene was BRCA2 (11%), followed by CHEK2 (5.5%), MUTYH (3.6%), and RAD51C (1.8%).
Conclusion
Male breast cancer in this cohort was predominantly luminal, high-grade, and frequently diagnosed at advanced stages. The high prevalence of germline pathogenic variants, including among patients without a strong family history, supports broader implementation of genetic counseling and multigene testing in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Instituto De Assistência Médica Ao Servidor Público Estadual, Pedro de Toledo, 1800, São Paulo, 04039-000, Brasil. patrickbatista64@gmail.com.
- A.C. Camargo Cancer Center, Tamandaré 753, São Paulo, SP, 01525-001, Brazil. patrickbatista64@gmail.com.
- Department of Oncology, Instituto de Assistência Médica ao Servidor Público Estadual (IAMSPE), São Paulo, Brazil. patrickbatista64@gmail.com.
- A.C. Camargo Cancer Center, Tamandaré 753, São Paulo, SP, 01525-001, Brazil.
- Department of Genetics, Institut Curie, Paris Sciences Lettre University, Paris, France.
- Department of Genetics, Gustave Roussy, Paris, France.
Förderung
- Instituto De Assistência Médica Ao Servidor Público Estadual
Zitieren
APA
Cerqueira, P. V. B. D., Campos, F. A. B., Caputo, S. M., Rouleau, E., Mantovani, H. K., da Silva, L. R., Cicilini, A. L., Sanches, S. M., Makdissi, F., da Costa, A. A. B. A., De Brot, M., Osório, C., Vasconcelos, V. C., de Lima, V. C., Casali da Rocha, J. C., Carraro, D., Torrezan, G., & Santana Dos Santos, E. (2026). Male breast cancer: clinicopathological features and prevalence of germline pathogenic variants. Breast Cancer Research and Treatment, 220(1). https://doi.org/10.1007/s10549-026-08062-9
Vancouver
Cerqueira PVBD, Campos FAB, Caputo SM, Rouleau E, Mantovani HK, da Silva LR, et al. Male breast cancer: clinicopathological features and prevalence of germline pathogenic variants. Breast Cancer Research and Treatment. 2026;220(1). doi:10.1007/s10549-026-08062-9
BibTeX
@article{Cerqueira2026,
author = {Cerqueira, P V B D and Campos, F A B and Caputo, S M and Rouleau, E and Mantovani, H K and da Silva, L R and Cicilini, A L and Sanches, S M and Makdissi, F and da Costa, A A B A and De Brot, M and Osório, C and Vasconcelos, V Castro and de Lima, V Cordeiro and Casali da Rocha, J C and Carraro, D and Torrezan, G and Santana Dos Santos, E},
title = {Male breast cancer: clinicopathological features and prevalence of germline pathogenic variants},
journal = {Breast Cancer Research and Treatment},
year = {2026},
volume = {220},
number = {1},
doi = {10.1007/s10549-026-08062-9}
}
EUVIMED